CA21135 “Modelling immunotherapy response and toxicity in cancer” (IMMUNO-model)

Datos básicos

Código:

EU23/13

Dotación:

Año Inicial:

2023

Año final:

2026

Objetivos del proyecto

The IMMUNO-model COST Action aims to foster research and innovation in the field of preclinical immuno-oncology models with the ultimate goal of advancing in the treatment of cancer patients by improving their outcomes and quality of life.

Unidades de investigación

• NANOMEDICINA

  

  Investigador Responsable

  Mónica López Fanarraga

  monica.lopez@unican.es